BEAT - Heartbeam Inc

BEAT - Heartbeam Inc

https://www.heartbeam.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

HeartBeam Cuts Costs Awaits FDA Decision

Motley Fool • 1 month ago • score: 0.13

HeartBeam ( NASDAQ:BEAT ) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The company finished with a $5.1 million cash balance and remains on track for FDA clearance of its ...

What's Going On With Heartbeam ( BEAT ) Stock? - HeartBeam ( NASDAQ:BEAT )

Benzinga • 1 year, 6 months ago • score: 0.40

Heartbeam Inc BEAT shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The earlier move higher came despite a lack of company-specific news for the session.

Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions - ( SSNGY ) , HeartBeam ( NASDAQ:BEAT )

Benzinga • 2 years, 3 months ago • score: 0.56

HeartBeam, Inc. BEAT shares are trading higher after entering a strategic alliance agreement with Samsung Electronics Co Ltd SSNGY SSNLF. The deal extends the existing pact between HeartBeam's recently-acquired LIVMOR and Samsung. The financial terms were not disclosed.

HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks - HeartBeam ( NASDAQ:BEAT )

Benzinga • 2 years, 9 months ago • score: 0.35

HeartBeam Inc BEAT announced that its patent for a 12-lead electrocardiogram ( ECG ) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office ( USPTO ) .

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.

52W High

$3.48

52W Low

$0.91

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.70

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.00

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

11.08

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

23.80%

Institutions (25–75% balanced)

10.48%

Shares Outstanding

34,311,600

Float

24,806,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-0.69

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-3.16%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.0781

Previous

0.0753

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025